Mesh : Humans Anti-Bacterial Agents / therapeutic use Pneumonia / drug therapy Community-Acquired Infections / drug therapy

来  源:   DOI:10.1055/s-0043-1777797

Abstract:
In 2023, the new European guidelines on severe community-acquired pneumonia, providing clinical practice recommendations for the management of this life-threatening infection, characterized by a high burden of mortality, morbidity, and costs for the society. This review article aims to summarize the principal evidence related to eight different questions covered in the guidelines, by also highlighting the future perspectives for research activity.
摘要:
2023年,新的欧洲严重社区获得性肺炎指南,为这种危及生命的感染的管理提供临床实践建议,以死亡率高负担为特征,发病率,以及社会的成本。这篇综述文章旨在总结与指南中涵盖的八个不同问题相关的主要证据,通过强调研究活动的未来前景。
公众号